Grant
Drug accelerator awards
Parkinson's UK awards translational research grants of up to £200,000 for up to 18 months to accelerate novel drug development for Parkinson's disease. Eligible applicants include UK universities, NHS Trusts, and small biotech startups.
See your fitKey facts
- Organiser
- Parkinson's UK
- Deadline
- January 14, 2027
- Cycles
- 2027 Round 1 · deadline January 14, 2027; 2027 Round 2 · deadline September 2, 2027
- Amount
- £200,000 · Grant
- Open to
- United Kingdom
- Sectors
- Biotech, Healthtech
3 details are locked
See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.
See your fitKey questions about Drug accelerator awards
Who can apply to Drug accelerator awards?
Eligible locations: United Kingdom. Only startups in these sectors qualify: Biotech and Healthtech. Other requirements: Must involve people with lived experience of Parkinson's in research process and application.
When is the Drug accelerator awards deadline?
The Drug accelerator awards deadline is January 14, 2027. Upcoming cycles: 2027 Round 1 · deadline January 14, 2027; 2027 Round 2 · deadline September 2, 2027. Next cycles: Round 1 preproposal deadline is 14 January 2027.
Other programs in this category
Verified on November 3, 2026 against the official page.